HUGE News and Press, FSD Pharma Inc. From 11/27/23

2023-11-27 08:51:16 ET More on FSD Pharma Financial information for FSD Pharma For further details see: FSD Pharma obtains final order for plan of arrangement from Ontario court

TORONTO, ON / ACCESSWIRE / November 27, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it obtained a final order on...

BALTIMORE, MD / ACCESSWIRE / November 24, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on FSD Pharma, Inc. (NASDAQ:HUGE)(CSE:HUGE) , an innovative biopharmaceutical...

Verisante Technology (VRSEF) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Horiba Ltd (HRIBF) is expected to report for Q3 2023 China Shenhua Energy Co Ltd ADR (CSUAY) is expected to report for Q3 2023 Denso Corpor...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that FSD Pharma securityholders (as defined in the announcement) have approved the previously disclosed plan of arrangement...

TORONTO, ON / ACCESSWIRE / November 21, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that the FSD Pharma Securityholde...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has announced the distribution date that its securityholders can expect to receive common shares in the capital of Celly Nutrition Corp. Th...

TORONTO, ON / ACCESSWIRE / November 17, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that, further to its press releas...

Bank of China Ltd. ADR (BACHY) is expected to report for Q2 2024 China Health Industries Holdings Inc (CHHE) is expected to report for quarter end 2023-09-30 Nitori Holdings Co., Ltd. ADR (NCLTY) is expected to report for Q2 2024 China Minsheng Banking Corporation Ltd. ADR (CMAKY) is ...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has filed a supplement related to certain restrictions on resale that will apply to the Celly Nu shares that will be distributed to the FSD...